64152-09-6 Usage
Uses
Used in Pharmaceutical Industry:
4-Nitro-3-methoxycarbonyl benzoic acid is used as an intermediate in the synthesis of various pharmaceuticals for its ability to be chemically modified to create a range of medicinal compounds. Its reactivity and functional groups make it a versatile building block in drug development.
Used in Dye Industry:
In the dye industry, 4-Nitro-3-methoxycarbonyl benzoic acid is used as a precursor in the production of dyes due to its capacity to form colored compounds when subjected to specific chemical reactions.
Used in Polymer Production:
4-Nitro-3-methoxycarbonyl benzoic acid is used as a monomer or a building block in the production of polymers, contributing to the development of materials with specific properties for various applications.
Used in Industrial Chemicals:
4-NITRO-3-METHOXYLCARBONYL BENZOIC ACID is also utilized in the production of other industrial chemicals, where its chemical structure and properties are leveraged to create a variety of products used across different sectors.
Safety and Environmental Considerations:
4-Nitro-3-methoxycarbonyl benzoic acid is considered a potentially hazardous substance, being toxic to aquatic organisms and capable of causing skin and eye irritation in humans. Therefore, it is crucial to handle and store 4-NITRO-3-METHOXYLCARBONYL BENZOIC ACID with care to minimize health risks and environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 64152-09-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,1,5 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 64152-09:
(7*6)+(6*4)+(5*1)+(4*5)+(3*2)+(2*0)+(1*9)=106
106 % 10 = 6
So 64152-09-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H7NO6/c1-16-9(13)6-4-5(8(11)12)2-3-7(6)10(14)15/h2-4H,1H3,(H,11,12)
64152-09-6Relevant academic research and scientific papers
Quinolinone compound and application thereof in drugs
-
, (2016/10/07)
The invention relates to a quinolinone compound and application thereof in drugs, particularly relates to a novel quinolinone compound, a pharmaceutical composition thereof and use of the compound or the pharmaceutical composition in preparing drugs. The drug is used for protecting, disposing, treating or alleviating HIF-related and/or EPO-related diseases of patients, wherein the HIF-related and/or EPO-related diseases comprise anemia, vascular diseases, regional myocardial ischaemia, metabolic disturbance, wound healing and the like.
NEUROTRYPSIN INHIBITORS
-
Page/Page column 57, (2012/05/20)
The invention relates to acylamino-phthalic acid amides and related compounds of formula (I) wherein A is -CONR3R4,-NR5COR6, -NHR7, -OR8, -mR9, -CH2NRI0R11, -(CH2)2-R12, -CH=CH-R12, -C=C-R12, optionally substituted phenyl, optionally substituted thiophenyl, or optionally substituted 1,2,3-triazol-4-yl, W is hydrogen, hydroxy or carboxymethoxy, Y is carboxy, methoxycarbonyl or 2H-tetrazol-5-yl, and the various substituents R have the meanings indicated in the description. These compounds are useful for the treatment and/or prophylaxis of skeletal muscle atrophy, schizophrenia and Alzheimer?s disease, and as cognitive enhancers.
Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives, compositions and use
-
, (2008/06/13)
The present invention relates to novel positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives having positive inotropic and lusitropic properties which are useful in the treatment of warm-blooded animals suffering from Congestive Heart Failure. Pharmaceutical compositions containing said compounds as an active ingredient. Methods of preparing said compounds and pharmaceutical compositions.
